Litcius/Paper detail

Covid-19: Innova lateral flow test is not fit for “test and release” strategy, say experts

Elisabeth Mahase

2020BMJ42 citationsDOI

Abstract

The government has claimed that rapid lateral flow covid-19 tests, which are being used in mass testing pilots in England and can provide results in 30 minutes, are “accurate and sensitive enough to be used in the community,” after evaluation results were published.1 However, experts warn that the tests may miss as many as half of covid-19 cases, depending on who is using them—making them unsuitable for a “test and release” strategy to enable people to leave lockdown or to allow students to go home from university. The ongoing assessment, carried out by Public Health England’s Porton Down laboratory and the University of Oxford, tested a number of lateral flow devices in different settings including hospitals, schools, and universities. The Innova SARS-CoV-2 Antigen Rapid Qualitative Test, which has been used in the Liverpool mass testing pilot to detect infections,2 is the …

Topics & Concepts

Test (biology)Coronavirus disease 2019 (COVID-19)Government (linguistics)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakMedical educationPublic healthMedicinePsychologyNursingVirologyPathologyOutbreakPaleontologyLinguisticsBiologyDiseasePhilosophyInfectious disease (medical specialty)SARS-CoV-2 detection and testingCOVID-19 epidemiological studiesCOVID-19 and healthcare impacts
Covid-19: Innova lateral flow test is not fit for “test and release” strategy, say experts | Litcius